InvestorsHub Logo
Followers 87
Posts 6759
Boards Moderated 1
Alias Born 09/18/2009

Re: LPF91 post# 33930

Saturday, 10/16/2021 10:28:13 AM

Saturday, October 16, 2021 10:28:13 AM

Post# of 43124
What better platform for "The Cytokine Storm Company" to announce regulatory approval than at, "...the world’s largest multidisciplinary organization advancing both fundamental and clinical research specific to the role of cytokines in health and disease?"

As I said, we were not initially scheduled to present at the Exhibitor Breaking News Session of the ICIS. I concluded that by noting that we weren't on the list of scheduled presenters. The only mention I see of that is in our PR, which only states that we are presenting "... data from (our) LIVE-AIR Phase 3 study." And that may very well be true. But we have now met with the Scientific Advisory Boards for both the US and the UK. I expect they may have voted and made their recommendations to the FDA and the MHRA by now. And with 1.5 hours now scheduled to kick-off the Exhibitor News Session, I think we may be hearing that they have voted to recommend our approvals.

I'm just doing what I always do, reading the tea leaves. Of course I could be wrong. But I have a rational basis for my conclusion, and really, it is well passed time that we were approved. So I'm very hopeful, especially for a CMA.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.